STOCK TITAN

[Form 4] Iridex Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

IRIDEX Corp (IRIX) Form 4: On 06/30/2025 President & CEO Patrick Mercer surrendered 4,243 common shares at $0.8819 under Transaction Code F. The shares were automatically withheld by the company to satisfy payroll-tax obligations tied to the net settlement of restricted stock units, so no open-market sale occurred.

After the withholding, Mercer still directly owns 415,857 IRIX shares, maintaining a significant equity stake. No derivative transactions were reported and there were no changes to his options or RSU schedule.

The disposition is valued at roughly $3.7 k, an amount that is immaterial relative to IRIDEX’s market capitalisation and Mercer's remaining holdings. As such, the filing carries limited market significance and is primarily an administrative compliance event.

IRIDEX Corp (IRIX) Modulo 4: Il 30/06/2025 il Presidente e CEO Patrick Mercer ha ceduto 4.243 azioni ordinarie a 0,8819 $ secondo il Codice di Transazione F. Le azioni sono state automaticamente trattenute dalla società per soddisfare gli obblighi fiscali legati al regolamento netto delle unità azionarie vincolate, quindi non è avvenuta alcuna vendita sul mercato aperto.

Dopo la trattenuta, Mercer possiede ancora direttamente 415.857 azioni IRIX, mantenendo una quota significativa di partecipazione azionaria. Non sono state segnalate transazioni derivati né modifiche al suo programma di opzioni o RSU.

La disposizione ha un valore approssimativo di 3,7 mila $, una cifra irrilevante rispetto alla capitalizzazione di mercato di IRIDEX e alle partecipazioni residue di Mercer. Pertanto, la comunicazione ha un significato limitato per il mercato ed è principalmente un evento di conformità amministrativa.

IRIDEX Corp (IRIX) Formulario 4: El 30/06/2025 el Presidente y CEO Patrick Mercer entregó 4.243 acciones comunes a $0.8819 bajo el Código de Transacción F. Las acciones fueron retenidas automáticamente por la empresa para cumplir con las obligaciones fiscales relacionadas con el pago de nómina vinculadas a la liquidación neta de unidades restringidas de acciones, por lo que no se realizó ninguna venta en el mercado abierto.

Tras la retención, Mercer aún posee directamente 415,857 acciones de IRIX, manteniendo una participación accionaria significativa. No se reportaron transacciones derivadas ni cambios en su programa de opciones o RSU.

La disposición tiene un valor aproximado de $3.7 mil, una cantidad insignificante en relación con la capitalización de mercado de IRIDEX y las participaciones restantes de Mercer. Por lo tanto, el informe tiene una importancia limitada en el mercado y es principalmente un evento de cumplimiento administrativo.

IRIDEX Corp (IRIX) 양식 4: 2025년 6월 30일, 사장 겸 CEO 패트릭 머서가 거래 코드 F에 따라 $0.8819에 보통주 4,243주를 반납했습니다. 이 주식들은 제한 주식 단위의 순결제와 관련된 급여세 의무를 충족하기 위해 회사가 자동으로 원천징수했으며, 따라서 공개 시장에서의 판매는 발생하지 않았습니다.

원천징수 후에도 머서는 여전히 직접 415,857주의 IRIX 주식을 보유하고 있어 상당한 지분을 유지하고 있습니다. 파생상품 거래는 보고되지 않았으며, 옵션이나 RSU 일정에도 변경이 없었습니다.

이번 처분의 가치는 약 3.7천 달러로 IRIDEX의 시가총액과 머서의 남은 보유분에 비해 미미한 금액입니다. 따라서 이 보고서는 시장에 미치는 영향이 제한적이며 주로 행정적 준수 이벤트입니다.

IRIDEX Corp (IRIX) Formulaire 4 : Le 30/06/2025, le Président & CEO Patrick Mercer a cédé 4 243 actions ordinaires à 0,8819 $ selon le Code de Transaction F. Les actions ont été automatiquement retenues par la société pour satisfaire aux obligations fiscales liées à la paie, associées au règlement net des unités d’actions restreintes, donc aucune vente sur le marché ouvert n’a eu lieu.

Après cette retenue, Mercer détient encore directement 415 857 actions IRIX, conservant une participation significative. Aucune transaction dérivée n’a été signalée et aucun changement n’a été apporté à son programme d’options ou d’unités d’actions restreintes.

La cession est valorisée à environ 3,7 k$, un montant négligeable par rapport à la capitalisation boursière d’IRIDEX et aux avoirs restants de Mercer. Ainsi, ce dépôt a une portée limitée sur le marché et constitue principalement un événement de conformité administrative.

IRIDEX Corp (IRIX) Formular 4: Am 30.06.2025 gab Präsident und CEO Patrick Mercer 4.243 Stammaktien zu 0,8819 $ gemäß Transaktionscode F ab. Die Aktien wurden vom Unternehmen automatisch einbehalten, um die lohnsteuerlichen Verpflichtungen im Zusammenhang mit der Nettoregelung von Restricted Stock Units zu erfüllen, sodass kein Verkauf am offenen Markt stattfand.

Nach dem Einbehalt besitzt Mercer weiterhin direkt 415.857 IRIX-Aktien und hält damit eine bedeutende Beteiligung. Es wurden keine Derivatgeschäfte gemeldet und es gab keine Änderungen an seinem Options- oder RSU-Plan.

Der Wert der Veräußerung liegt bei etwa 3,7 Tsd. $, ein Betrag, der im Verhältnis zur Marktkapitalisierung von IRIDEX und Mercers verbleibenden Beständen unerheblich ist. Daher hat die Meldung eine begrenzte Marktbedeutung und stellt hauptsächlich ein administratives Compliance-Ereignis dar.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding; negligible dollar value; neutral for valuation.

Code F indicates an exempt share surrender to cover taxes, not an open-market sale. Only 4,243 shares (≈$3.7 k) were withheld, leaving the CEO with 415,857 shares. The tiny size and non-cash nature mean this Form 4 does not alter ownership incentives or signal sentiment. I classify the impact as routine and non-material.

TL;DR: Administrative move, maintains strong management alignment.

Such F-code transactions show compliance with Rule 16b-3(e). Crucially, Mercer retains more than 400 k shares, supporting shareholder-management alignment. No red flags on insider selling or control changes. Market impact: neutral.

IRIDEX Corp (IRIX) Modulo 4: Il 30/06/2025 il Presidente e CEO Patrick Mercer ha ceduto 4.243 azioni ordinarie a 0,8819 $ secondo il Codice di Transazione F. Le azioni sono state automaticamente trattenute dalla società per soddisfare gli obblighi fiscali legati al regolamento netto delle unità azionarie vincolate, quindi non è avvenuta alcuna vendita sul mercato aperto.

Dopo la trattenuta, Mercer possiede ancora direttamente 415.857 azioni IRIX, mantenendo una quota significativa di partecipazione azionaria. Non sono state segnalate transazioni derivati né modifiche al suo programma di opzioni o RSU.

La disposizione ha un valore approssimativo di 3,7 mila $, una cifra irrilevante rispetto alla capitalizzazione di mercato di IRIDEX e alle partecipazioni residue di Mercer. Pertanto, la comunicazione ha un significato limitato per il mercato ed è principalmente un evento di conformità amministrativa.

IRIDEX Corp (IRIX) Formulario 4: El 30/06/2025 el Presidente y CEO Patrick Mercer entregó 4.243 acciones comunes a $0.8819 bajo el Código de Transacción F. Las acciones fueron retenidas automáticamente por la empresa para cumplir con las obligaciones fiscales relacionadas con el pago de nómina vinculadas a la liquidación neta de unidades restringidas de acciones, por lo que no se realizó ninguna venta en el mercado abierto.

Tras la retención, Mercer aún posee directamente 415,857 acciones de IRIX, manteniendo una participación accionaria significativa. No se reportaron transacciones derivadas ni cambios en su programa de opciones o RSU.

La disposición tiene un valor aproximado de $3.7 mil, una cantidad insignificante en relación con la capitalización de mercado de IRIDEX y las participaciones restantes de Mercer. Por lo tanto, el informe tiene una importancia limitada en el mercado y es principalmente un evento de cumplimiento administrativo.

IRIDEX Corp (IRIX) 양식 4: 2025년 6월 30일, 사장 겸 CEO 패트릭 머서가 거래 코드 F에 따라 $0.8819에 보통주 4,243주를 반납했습니다. 이 주식들은 제한 주식 단위의 순결제와 관련된 급여세 의무를 충족하기 위해 회사가 자동으로 원천징수했으며, 따라서 공개 시장에서의 판매는 발생하지 않았습니다.

원천징수 후에도 머서는 여전히 직접 415,857주의 IRIX 주식을 보유하고 있어 상당한 지분을 유지하고 있습니다. 파생상품 거래는 보고되지 않았으며, 옵션이나 RSU 일정에도 변경이 없었습니다.

이번 처분의 가치는 약 3.7천 달러로 IRIDEX의 시가총액과 머서의 남은 보유분에 비해 미미한 금액입니다. 따라서 이 보고서는 시장에 미치는 영향이 제한적이며 주로 행정적 준수 이벤트입니다.

IRIDEX Corp (IRIX) Formulaire 4 : Le 30/06/2025, le Président & CEO Patrick Mercer a cédé 4 243 actions ordinaires à 0,8819 $ selon le Code de Transaction F. Les actions ont été automatiquement retenues par la société pour satisfaire aux obligations fiscales liées à la paie, associées au règlement net des unités d’actions restreintes, donc aucune vente sur le marché ouvert n’a eu lieu.

Après cette retenue, Mercer détient encore directement 415 857 actions IRIX, conservant une participation significative. Aucune transaction dérivée n’a été signalée et aucun changement n’a été apporté à son programme d’options ou d’unités d’actions restreintes.

La cession est valorisée à environ 3,7 k$, un montant négligeable par rapport à la capitalisation boursière d’IRIDEX et aux avoirs restants de Mercer. Ainsi, ce dépôt a une portée limitée sur le marché et constitue principalement un événement de conformité administrative.

IRIDEX Corp (IRIX) Formular 4: Am 30.06.2025 gab Präsident und CEO Patrick Mercer 4.243 Stammaktien zu 0,8819 $ gemäß Transaktionscode F ab. Die Aktien wurden vom Unternehmen automatisch einbehalten, um die lohnsteuerlichen Verpflichtungen im Zusammenhang mit der Nettoregelung von Restricted Stock Units zu erfüllen, sodass kein Verkauf am offenen Markt stattfand.

Nach dem Einbehalt besitzt Mercer weiterhin direkt 415.857 IRIX-Aktien und hält damit eine bedeutende Beteiligung. Es wurden keine Derivatgeschäfte gemeldet und es gab keine Änderungen an seinem Options- oder RSU-Plan.

Der Wert der Veräußerung liegt bei etwa 3,7 Tsd. $, ein Betrag, der im Verhältnis zur Marktkapitalisierung von IRIDEX und Mercers verbleibenden Beständen unerheblich ist. Daher hat die Meldung eine begrenzte Marktbedeutung und stellt hauptsächlich ein administratives Compliance-Ereignis dar.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Mercer Patrick

(Last) (First) (Middle)
1212 TERRA BELLA AVENUE

(Street)
MOUNTAIN VIEW CA 94043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 F 4,243(1) D $0.8819 415,857 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares have been withheld in an exempt disposition to the Issuer under Rule 16b-3(e), to satisfy the Issuer's income tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.
/s/ Nilo De Castro, Attorney-in-fact for Patrick Mercer 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IRIX report on 06/30/2025?

CEO Patrick Mercer surrendered 4,243 common shares to cover tax withholding obligations (Code F).

Did the IRIX CEO sell shares on the open market?

No. The shares were withheld by the company for taxes; no open-market sale occurred.

How many IRIX shares does Patrick Mercer own after the filing?

He now directly owns 415,857 common shares.

What is Transaction Code F on a Form 4?

Code F denotes shares withheld by the issuer to pay withholding taxes on equity awards; it is an exempt disposition.

Is the reported transaction material to IRIX investors?

The value (≈$3.7 k) is immaterial and does not signal a change in management’s holdings or outlook.
Iridex

NASDAQ:IRIX

IRIX Rankings

IRIX Latest News

IRIX Latest SEC Filings

IRIX Stock Data

16.79M
12.06M
20.67%
19.45%
1.6%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
MOUNTAIN VIEW